🇺🇸 FDA

Drug profile · INN

gadobenate dimeglumine

MULTIHANCE

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

gadobenate dimeglumine (MULTIHANCE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN gadobenate dimeglumine
Brand MULTIHANCE
Route INTRAVENOUS
Formulation INJECTABLE

Frequently asked questions

What is gadobenate dimeglumine?

gadobenate dimeglumine (MULTIHANCE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for gadobenate dimeglumine?

MULTIHANCE is a marketed brand name for gadobenate dimeglumine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of gadobenate dimeglumine?

gadobenate dimeglumine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.